Activists write to PM Modi on unethical practices at Covaxin's Bhopal trial site
Premium
Bhopal: A medic administers Covaxin, developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), during the Phase- 3 trials at Peoples College of Medical Sciences & Research Centre in Bhopal.
(PTI)
Bharat Biotech, in its statement, said that the Covaxin Phase 3 study is being conducted across 26 sites in India in compliance with the study protocol, Indian good clinical practice guidelines, and all regulatory provisions that apply to clinical trials in the country
Share Via
Read Full Story
Activists involved with the Bhopal gas tragedy have written to Prime Minister Narendra Modi and health minister Harsh Vardhan about the unethical practices at the clinical trial site for Bharat Biotech's Covaxin at the city’s Peoples College of Medical Sciences & Research Centre.